Gavin M. Bendle - Division of Immunology, The Netherlands Cancer Institute

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 45 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Non-clinical evaluation of NT-112, an autologous T cell product engineered to express an HLA-C*08:02-restricted TCR targeting KRAS G12D and resistant to TGF-b inhibition

Jennifer Ma, Vanessa Tubb, Michelle Mojadidi, Kayla Meade,Xiangjun Kong,Paula Kroon, Aastha Sareen, Bas Stringer,Oscar Krijgsman, Yvonne Claasen,Jules Gadiot, Karen Buchner,

Journal of Clinical Oncologyno. 16_suppl (2024)

Cited0Views0Bibtex

Non-clinical evaluation of NT-175, an autologous T cell product engineered to express an HLA-A*02:01-restricted TCR targeting TP53 R175H and resistant to TGF-b inhibition

Vanessa Tubb, Jennifer Ma, Karen Buchner,Sander Eshuis, Michelle Mojadidi,Xiangjun Kong,Paula Kroon, Aastha Sareen, Rojina Duwal,Laura Bies, Julia Walker,Robbert Spaapen,

Journal of Clinical Oncologyno. 16_suppl (2024): 2560-2560

Cited0Views0Bibtex

Data from Neuroblastoma Arginase Activity Creates an Immunosuppressive Microenvironment That Impairs Autologous and Engineered Immunity

Francis Mussai,Sharon Egan,Stuart Hunter,Hannah Webber,Jonathan Fisher,Rachel Wheat, Carmel McConville,Yordan Sbirkov,Kate Wheeler,Gavin Bendle,Kevin Petrie,John Anderson,

crossref（2023）

Cited0Views0Bibtex

Development of a personalized neoantigenspecific tcr discovery platform

Robbert Spaapen,Thomas Kuilman,Bo Schrikkema,Jules Gadiot,Raquel Gomez, Julia Walker,Laura Bies,Oscar Krijgsman,Yvonne Claassen,Milena Viyacheva,Demi Houg,Manuel Soarnil,

Regular and Young Investigator Award Abstracts (2022): A255-A255

Cited0Views0Bibtex

239 Engineering of potency-enhanced TCR-edited T cells for shared neoantigen-targeted cancer immunotherapy

Lianne Kok,Sander Eshuis,Paula Kroon, Vanessa Tubb,Xiangjun Kong,Carsten Linnemann,Gavin Bendle,Jeroen van Heijst

Regular and Young Investigator Award Abstracts (2022): A253-A253

Cited0Views0Bibtex

The common HLA class I-restricted tumor-infiltrating T cell response in HPV16-induced cancer

Saskia J. Santegoets,Marij J. P. Welters, Deborah S. Schrikkema, Manon R. Freriks,Hanna Kok,Bianca Weissbrich, Anouk van den Branden,Carsten Linnemann,Ton N. Schumacher,Sabina Adhikary,Gavin Bendle,Sjoerd H. van der Burg

Cancer Immunol Immunother（2022）

Cited2Views0WOSBibtex

Safety and efficacy of Tet-regulated IL-12 expression in cancer-specific T cells

Ahdab Alsaieedi,Angelika Holler,Pedro Velica,Gavin Bendle,Hans J Stauss

ONCOIMMUNOLOGY（2019）

Cited23Views0WOSBibtex

Isolation of T cell receptors targeting recurrent neoantigens in hematological malignancies

Vanessa M. Tubb, Deborah S. Schrikkema,Nathan P. Croft,Anthony W. Purcell,Carsten Linnemann, Manon R. Freriks,Frederick Chen,Heather M. Long,Steven P. Lee,Gavin M. Bendle

Journal for immunotherapy of cancer（2018）

Cited27Views0WOSBibtex

Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers

Wouter Scheper,Sander Kelderman,Lorenzo F. Fanchi,Carsten Linnemann,Gavin Bendle,Marije A. J. de Rooij,Christian Hirt,Riccardo Mezzadra,Maarten Slagter,Krijn Dijkstra,Roelof J. C. Kluin,Petur Snaebjornsson,

NATURE MEDICINE（2018）

Cited391Views0WOSNATUREBibtex

391

Neuroblastoma Arginase Activity Creates An Immunosuppressive Microenvironment That Impairs Autologous And Engineered Immunity

Francis Mussai,Sharon A Egan,S Hunter,Hannah Webber,J Fisher,Rachel Wheat,C M Mcconville,Yordan Sbirkov,Kate Ah Wheeler,Gavin Bendle,Kevin Petrie,John Anderson,

CANCER RESEARCH（2015）

Cited78Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn